Moon Capital Management liquidated its holdings in
CVS Health Corporation with a modest gain while
International Assets Investment Management holds $495,000 in the company. The wellness company further announced a
quarterly dividend, while CVS Health and
Aetna granted $750,000 to health-improving organizations in Illinois. The stock has outperformed competitors on a strong trading day and saw a 3.51% increase on January 3. Analysts, however, have lowered the
price target of the stock from $67 to $60. With a new CEO aiming to revive the company, CVS Health is reportedly considering a
spin-off of its insurance business. The earnings missed analyst estimates, but the company has presented a strong performance in the retail pharmacy sector, making the company an attractive investment opportunity. While there was a proposal for a break-up due to financial challenges, some investors, like
Glenview Capital, do not want the company to split. Despite numerous challenges, CVS Health maintains an integrated model and often provides flu and COVID-19 vaccinations at its pharmacies. While CVS stock goes ex-dividend soon, it continues to attract investors as a potential undervalued investment.
Cvs Health Corporation CVS News Analytics from Thu, 25 Apr 2024 07:00:00 GMT to Sat, 11 Jan 2025 09:22:50 GMT -
Rating -4
- Innovation -2
- Information 6
- Rumor 3
